Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EARN
1426
Ellington Residential Mortgage REIT
EARN
$166M
| $10.3M | 0.01% |
948,000
-6,900
| -0.7% | -$75.3K |
|
|
AIMC
1427
DELISTED
Altra Industrial Motion Corp
AIMC
| $10.3M | 0.01% |
284,013
+159,504
| +128% | +$5.07M |
|
|
ESGR
1428
DELISTED
Enstar Group
ESGR
| $10.3M | 0.01% |
49,700
-17,900
| -26% | -$3.58M |
|
1429
Designer Brands
DBI
$299M
| $10.2M | 0.01% |
650,630
+541,600
| +497% | +$8.97M |
|
1430
Warner Bros
WBD
$69.5B
| $10.2M | 0.01% |
+312,350
| New | +$9.41M |
|
|
SPPI
1431
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $10.2M | 0.01% |
2,803,300
+38,283
| +1% | +$309K |
|
|
DPLO
1432
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $10.2M | 0.01% |
2,550,960
+2,346,060
| +1,145% | +$11M |
|
|
ENLC
1433
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $10.2M | 0.01% |
1,664,446
+1,552,237
| +1,383% | +$9.42M |
|
1434
iShares US Real Estate ETF
IYR
$4.6B
| $10.2M | 0.01% |
109,600
-97,600
| -47% | -$9.05M |
|
1435
Endava
DAVA
$164M
| $10.2M | 0.01% |
218,063
+76,603
| +54% | +$3.3M |
|
|
TMX
1436
DELISTED
Terminix Global Holdings, Inc.
TMX
| $10.1M | 0.01% |
261,800
-202,300
| -44% | -$8.6M |
|
1437
Viatris
VTRS
$18.6B
| $10.1M | 0.01% |
+503,100
| New | +$9.36M |
|
1438
Victory Capital Holdings
VCTR
$7.29B
| $10.1M | 0.01% |
481,995
-15,252
| -3% | -$277K |
|
|
HONE
1439
DELISTED
HarborOne Bancorp
HONE
| $10.1M | 0.01% |
919,076
+112,800
| +14% | +$1.18M |
|
1440
West Bancorporation
WTBA
$508M
| $10.1M | 0.01% |
393,752
+23,200
| +6% | +$552K |
|
|
PARA
1441
DELISTED
Paramount Global Class B
PARA
| $10.1M | 0.01% |
+240,397
| New | +$9.31M |
|
1442
Varex Imaging
VREX
$779M
| $10.1M | 0.01% |
338,400
+149,500
| +79% | +$4.47M |
|
|
NOA
1443
North American Construction
NOA
$374M
| $10.1M | 0.01% |
830,300
-210,300
| -20% | -$2.35M |
|
|
SGEN
1444
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.1M | 0.01% |
88,013
+44,400
| +102% | +$4.71M |
|
1445
Ironwood Pharmaceuticals
IRWD
$694M
| $10M | 0.01% |
753,690
+667,637
| +776% | +$7.36M |
|
1446
Consolidated Water Co
CWCO
$500M
| $10M | 0.01% |
615,184
+65,786
| +12% | +$1.09M |
|
|
KIN
1447
DELISTED
Kindred Biosciences, Inc.
KIN
| $10M | 0.01% |
1,179,298
-26,400
| -2% | -$206K |
|
1448
Vera Bradley
VRA
$94.7M
| $9.99M | 0.01% |
847,000
-303,407
| -26% | -$3.36M |
|
1449
Monarch Casino & Resort
MCRI
$2.23B
| $9.98M | 0.01% |
205,603
+7,800
| +4% | +$347K |
|
|
CAMP
1450
DELISTED
CalAmp Corp.
CAMP
| $9.98M | 0.01% |
45,274
-2,839
| -6% | -$692K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.